Predictive Value of Interim and End-of-Therapy 18F-FDG PET/CT in Patients with Follicular Lymphoma.
Sun Ha BooJoo Hyun OSoo Jin KwonIe Ryung YooSung Hoon KimGyeong Sin ParkByung Ock ChoiSeung Eun JungSeok-Goo ChoPublished in: Nuclear medicine and molecular imaging (2019)
For patients with FL, PETInterim and PETEOI response is predictive of PFS, and PETEOI(+) is an independent prognostic factor for progression of FL.
Keyphrases